Cargando…

STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway

Oncosuppressor TP53 and oncogene STAT3 have been shown to engage an interplay in which they negatively influence each other. Conversely, mutant (mut) p53 may sustain STAT3 phosphorylation by displacing SH2 phosphatase while whether STAT3 could influence mutp53 has not been clarified yet. In this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Romeo, Maria Anele, Gilardini Montani, Maria Saveria, Benedetti, Rossella, Santarelli, Roberta, D'Orazi, Gabriella, Cirone, Mara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367154/
https://www.ncbi.nlm.nih.gov/pubmed/32754441
http://dx.doi.org/10.3389/fonc.2020.01102
_version_ 1783560363679154176
author Romeo, Maria Anele
Gilardini Montani, Maria Saveria
Benedetti, Rossella
Santarelli, Roberta
D'Orazi, Gabriella
Cirone, Mara
author_facet Romeo, Maria Anele
Gilardini Montani, Maria Saveria
Benedetti, Rossella
Santarelli, Roberta
D'Orazi, Gabriella
Cirone, Mara
author_sort Romeo, Maria Anele
collection PubMed
description Oncosuppressor TP53 and oncogene STAT3 have been shown to engage an interplay in which they negatively influence each other. Conversely, mutant (mut) p53 may sustain STAT3 phosphorylation by displacing SH2 phosphatase while whether STAT3 could influence mutp53 has not been clarified yet. In this study we found that pharmacologic or genetic inhibition of STAT3 in both glioblastoma and pancreatic cancer cells, carrying mutp53 protein, reduced mutp53 expression level by down-regulating chaperone HSP90 as well as molecules belonging to the mevalonate pathway. On the other hand, HSP90 and the mevalonate pathway were involved in sustaining STAT3 phosphorylation mediated by mutp53. In conclusion, this study unveils for the first time that mutp53 can establish with STAT3, similarly to what observed with other oncogenic pathways, a criminal alliance with a crucial role in promoting cancerogenesis.
format Online
Article
Text
id pubmed-7367154
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-73671542020-08-03 STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway Romeo, Maria Anele Gilardini Montani, Maria Saveria Benedetti, Rossella Santarelli, Roberta D'Orazi, Gabriella Cirone, Mara Front Oncol Oncology Oncosuppressor TP53 and oncogene STAT3 have been shown to engage an interplay in which they negatively influence each other. Conversely, mutant (mut) p53 may sustain STAT3 phosphorylation by displacing SH2 phosphatase while whether STAT3 could influence mutp53 has not been clarified yet. In this study we found that pharmacologic or genetic inhibition of STAT3 in both glioblastoma and pancreatic cancer cells, carrying mutp53 protein, reduced mutp53 expression level by down-regulating chaperone HSP90 as well as molecules belonging to the mevalonate pathway. On the other hand, HSP90 and the mevalonate pathway were involved in sustaining STAT3 phosphorylation mediated by mutp53. In conclusion, this study unveils for the first time that mutp53 can establish with STAT3, similarly to what observed with other oncogenic pathways, a criminal alliance with a crucial role in promoting cancerogenesis. Frontiers Media S.A. 2020-07-10 /pmc/articles/PMC7367154/ /pubmed/32754441 http://dx.doi.org/10.3389/fonc.2020.01102 Text en Copyright © 2020 Romeo, Gilardini Montani, Benedetti, Santarelli, D'Orazi and Cirone. http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Romeo, Maria Anele
Gilardini Montani, Maria Saveria
Benedetti, Rossella
Santarelli, Roberta
D'Orazi, Gabriella
Cirone, Mara
STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title_full STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title_fullStr STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title_full_unstemmed STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title_short STAT3 and mutp53 Engage a Positive Feedback Loop Involving HSP90 and the Mevalonate Pathway
title_sort stat3 and mutp53 engage a positive feedback loop involving hsp90 and the mevalonate pathway
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7367154/
https://www.ncbi.nlm.nih.gov/pubmed/32754441
http://dx.doi.org/10.3389/fonc.2020.01102
work_keys_str_mv AT romeomariaanele stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway
AT gilardinimontanimariasaveria stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway
AT benedettirossella stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway
AT santarelliroberta stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway
AT dorazigabriella stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway
AT cironemara stat3andmutp53engageapositivefeedbackloopinvolvinghsp90andthemevalonatepathway